Cronos Group Inc. (CRON)
Cronos Group Inc. (CRON) from its SEC filings: 2025 revenue $146.6 million (+25% vs the year before), net margin -2%, free cash flow $149,000. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Medicinal Chemicals & Botanical Products |
| Revenue (2025) | $146.6 million |
| Revenue growth | +25% |
| Net income | -$2.9 million |
| Net margin | -2.0% |
| Free cash flow | $149,000 |
| Diluted EPS | $-0.02 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +58% |
| Cash | $467.0 million |
| Share count, 1 year | -4% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.